NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The company’s CEO wrote to employees that “sometimes it feels awkward to navigate being both on-mission and on-money.”Read More
